Kazia Therapeutics KZIA
NASDAQ KZIA
$8.07 -0.11 (-1.34%)
At close: Oct 22, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Accumulated Expenses (2012 - 2017)

Updated

Analysis

Kazia Therapeutics (KZIA) Accumulated Expenses (2012 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Kazia Therapeutics 586,024.22 -51.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 471,872.12
Dec 31, 2016 562,870.77
Aug 30, 2013 74,534.50
Jun 30, 2013 77,965.48
Dec 31, 2012 1.83 Mn
API Access

Kazia Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KZIA&period=max&api_key=YOUR_API_KEY